7-5481786-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_024963.6(FBXL18):c.2146C>A(p.Leu716Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,613,366 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024963.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXL18 | NM_024963.6 | c.2146C>A | p.Leu716Met | missense_variant | 5/5 | ENST00000382368.8 | NP_079239.3 | |
FBXL18 | NM_001367780.1 | c.1846C>A | p.Leu616Met | missense_variant | 5/5 | NP_001354709.1 | ||
FBXL18 | NM_001367781.1 | c.1846C>A | p.Leu616Met | missense_variant | 5/5 | NP_001354710.1 | ||
FBXL18 | NM_001363441.2 | c.2000+9445C>A | intron_variant | NP_001350370.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXL18 | ENST00000382368.8 | c.2146C>A | p.Leu716Met | missense_variant | 5/5 | 5 | NM_024963.6 | ENSP00000371805.3 | ||
FBXL18 | ENST00000415009.5 | n.2000+9445C>A | intron_variant | 2 | ENSP00000415064.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152236Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461130Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726896
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152236Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2023 | The c.2146C>A (p.L716M) alteration is located in exon 5 (coding exon 5) of the FBXL18 gene. This alteration results from a C to A substitution at nucleotide position 2146, causing the leucine (L) at amino acid position 716 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at